Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on...The Link Between Alcohol & Cancer: With Noelle Loconte, MD, Associate Professor of Medicine, Division of Hematology/Oncology, University of Wisconsin

  Sarah DiGiulio

• Free

  An Assortment of Journal Abstracts to Enhance Oncology Care
• Free

  CAR T-Cell Therapy Induces Long-Lasting Responses in Refractory NHL

  Mark L. Fuerst

• Free

  CAR T-Cell Therapy Induces Sustained Responses in DLBCL

  Mark L. Fuerst

• Free

  Combination of Ibrutinib & Venetoclax Shows Promise in Previously Treated CLL

  Mark L. Fuerst

• Free

  Drug Combo Kick-Starts Immune System to Fight Cancer
• Free

  First-Line Daratumumab Benefit in Multiple Myeloma

  Peter M. Goodwin

• Free

  For Women With Genetic Risk, Biannual MRI Beats Mammograms
• Free

  Learning the Leadership Levels in Your Cancer Center

  Brian J. Bolwell MD, FACP

• Free

  Mogamulizumab Outperforms Vorinostat in Previously Treated CTCL Patients

  Mark L. Fuerst

• Free

  Nilotinib Label Updated With Treatment-Free Remission Data
• Free

  Obinutuzumab Plus Venetoclax Induces Deep Durable Responses in CLL

  Mark L. Fuerst

• Free

  Pertuzumab Approved for Adjuvant Breast Cancer Treatment
• Free

  Presurgical Targeted Therapy Delays Relapse of High-Risk Stage III Melanoma
• Free

  Shop Talk
• Free

  Single-Cell RNA Sequencing Could Improve Myeloma Treatment

  Catlin Nalley

• Free

  Stereotactic Radiotherapy System Cleared for Breast Cancer
• Free

  The Response of Genetic Mutations on Immune Checkpoint Blockade

  Brandon May

• Free

  Venetoclax-Rituximab Combo Outperforms Standard Chemo in Refractory CLL

  Mark L. Fuerst

• Buy

  New Report Tracks Explosive Global Growth of Immuno-Oncology

  Peggy Eastman

• Buy

  Turning Stressed Immune Cells Back Into Fierce Cancer Fighters

  Valerie Neff Newitt